Durgical
EN
Open the app

Ibandronic acid

  • BisphosphonatesBisphosphonates

A nitrogen-containing bisphosphonate taken by mouth or given into a vein. It slows bone loss in postmenopausal osteoporosis.

Updated

Also called: Ibandronate

Quick facts

Group
Bisphosphonates
Target
Farnesyl pyrophosphate synthase (FPPS) in osteoclasts
Used for
Treatment and prevention
Key effects
Heartburn · Headache and dizziness · Bone
Monitor
Serum calcium · Kidney function · Dental health before
ATC
M05BA06

No doses: the clinician sets them by the current guideline.

Mechanism of action

The figure shows ibandronate itself in the active site of human farnesyl pyrophosphate synthase (crystal structure).

Target in 3D: Farnesyl pyrophosphate synthase (FPPS) in osteoclasts. PDB structure 2F94 (RCSB PDB, public domain). View the structure at RCSB PDB

Ibandronic acid binds bone mineral and is taken up by osteoclasts as they resorb bone. Inside the osteoclast it inhibits farnesyl pyrophosphate synthase in the mevalonate pathway, so small GTPases cannot be prenylated; the osteoclast loses its resorbing function and dies. Bone breakdown slows and bone density increases.

  1. Ibandronate binds bone mineral at resorption sites
  2. Osteoclasts take it up while resorbing bone
  3. FPPS inhibition blocks protein prenylation
  4. Osteoclasts stop working; bone loss slows

Indications

  • Treatment and prevention of osteoporosis in postmenopausal women Osteoporosis →

Adverse effects

Common

  • Heartburn, nausea, abdominal pain, diarrhoea or constipation
  • Headache and dizziness
  • Bone, muscle or joint pain
  • Flu-like symptoms after the first intravenous dose

Contraindications

  • Hypocalcaemia not corrected
  • For tablets: inability to stand or sit upright for 60 minutes, or oesophageal disorders that delay emptying
  • Caution: kidney disease

Key interactions

Calcium, antacids, iron, vitamins and other oral medicines
Block absorption; they are taken at least 60 minutes after the tablet
Aspirin and NSAIDs
More stomach and oesophageal irritation

What is monitored

  • Serum calcium and vitamin D before starting
  • Kidney function
  • Dental health before and during treatment
  • Bone mineral density

Administration and safety

  • Tablet: first thing in the morning on an empty stomach, swallowed whole with plain water only
  • The person stays upright and takes no food, drink or other medicine for 60 minutes
  • Injection: into a vein by a health professional, every 3 months and not more often

Pregnancy and breastfeeding

It is used after menopause. It stays in bone for years, so future pregnancy plans are discussed before use in younger people.

Nursing care

  • Teach the tablet routine exactly; errors cause oesophagitis or no absorption
  • Ask about heartburn, painful swallowing or chest pain
  • Encourage a dental check and good oral hygiene
  • Encourage adequate calcium and vitamin D
  • Ask about new thigh or groin pain

Pharmacokinetics

Absorption
Very poor by mouth and blocked by food, drinks other than plain water, and minerals; also given intravenously
Distribution
Binds bone and stays there for years

Test yourself

Think of the answer, then tap the question to see it.

Which enzyme do nitrogen-containing bisphosphonates such as ibandronate inhibit?

Farnesyl pyrophosphate synthase in the osteoclast mevalonate pathway, which blocks prenylation of small GTPases.

Why must ibandronate tablets be taken with plain water and the person stay upright for 60 minutes?

Food, drinks and minerals block its tiny absorption, and lying down lets it irritate the oesophagus.

Which rare jaw and femur complications are shared by bisphosphonates?

Osteonecrosis of the jaw and atypical femoral fracture.

Add to my cards (3)

More Pharmacology questions →

Connections

← Back to the class: Bisphosphonates

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Ibandronate: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); Ibandronate Injection: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.